Prednisolone
Visa No.: 893110453324
Product: Prencoid
API: Prednisolone
Product Category: Anti-inflammatories
Version approved leaflet: 31782e/QLD- ĐK_05/09/2025
INDICATIONS
Indicated for the treatment of bronchial asthma, allergic diseases, rheumatoid arthritis, rheumatic disorders, Still’s disease, rheumatic fever, psoriasis, osteoarthritis, osteomyelitis, gouty arthritis, acute and chronic gout, and other inflammatory skin diseases.
DOSAGE AND ADMINISTRATION
Connective tissue disorders
Rheumatoid arthritis: The initial dose of Prednisolone is 5 mg, taken as a single morning dose or on alternate days. The maintenance dose depends on the patient’s response. If there is no adequate response, the dose may be increased by 1 mg on alternate days over several weeks, up to a maximum of 10 mg per day.
Rheumatic carditis: Corticosteroids are used in patients who respond poorly to salicylates or cannot tolerate them at high doses. The usual dose is 1 mg/kg/day, given as a single dose or in pided doses for 7–10 days, followed by a gradual reduction of 2.5 mg/day every 5–7 days.
Asthma and other respiratory disorders:
Prednisolone 5–10 mg daily, given as a single dose or in pided doses. Higher doses may be used temporarily during severe episodes.
The initial adult dose may range from 5 to 60 mg per day, depending on the condition and severity, and is usually pided into 2–4 doses. During maintenance, after symptom improvement, the dose may be reduced by ½ to 1 tablet every 2–3 days.
The dose should be adjusted according to symptoms and age, and must follow the physician’s prescription.
Route of administration: Oral use.
CONTRAINDICATIONS
Severe infections, except septic shock and tuberculous meningitis.
Known hypersensitivity to Prednisolone.
Cutaneous infections caused by viruses, fungi, or tuberculosis.
Concomitant use with live virus vaccines.
WARNINGS AND PRECAUTIONS
Prescription only medicine. Read the instructions before use. Consult a physician or pharmacist if needed. Keep out of reach of children.
